Article Text

Download PDFPDF
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology
  1. C Berasain*,a,
  2. M Betés*,a,
  3. A Panizob,
  4. J Ruiza,
  5. J I Herreroa,
  6. M-P Civeiraa,
  7. J Prietoa
  1. aDepartment of Medicine and Liver Unit, Medical School and Clínica Universitaria, University of Navarra, Pamplona, Spain, bDepartment of Pathology, Medical School and Clínica Universitaria, University of Navarra, Pamplona, Spain
  1. Professor J Prieto, Department of Medicine and Liver Unit, Clínica Universitaria, Universidad de Navarra, Avda, Pio XII s/n, 31080 Pamplona, Spain. Email: jprieto{at}unav.es

Abstract

BACKGROUND The histopathological spectrum and role of hepatitis viruses in cases of hypertransaminasaemia of unknown aetiology have not been correctly analysed in a sufficiently large number of patients.

METHODS We studied 1075 consecutive patients referred for liver biopsy because of elevation of alanine aminotransferase (ALT) levels for more than six months. From this population we selected those cases in whom the aetiology could not be defined from clinical, biochemical, and serological data obtained before biopsy. In these patients liver biopsies were reviewed, and hepatitis B virus (HBV)-DNA and hepatitis C virus (HCV)-RNA were assayed in serum by polymerase chain reaction (PCR). Serum hepatitis G virus (HGV)-RNA was determined by PCR in 74 patients.

RESULTS Of 1075 patients studied, the cause of the increased serum ALT levels remained elusive after appropriate testing in 109 patients (10.1%). Liver biopsies from these patients showed non-specific changes in 32.7% of cases, non-alcoholic steatohepatitis (NASH) in 15.8%, and chronic hepatitis or cirrhosis in 51.5%. HBV-DNA and/or HCV-RNA was detected more frequently in cryptogenic liver disease than in healthy blood donors (26.7% v 3.4%; p<0.001). HGV-RNA was found in only one patient. The proportion of cases with detectable HBV-DNA or HCV-RNA was 14.3% in patients with non-specific changes or NASH, 30.7% in patients with chronic hepatitis, and 61.5% in patients with cirrhosis. Cirrhosis was found more frequently in patients with positive HBV-DNA and/or HCV-RNA in serum than in those who tested negatively (p=0.005).

CONCLUSIONS In our series, patients in whom biochemical and serological data did not determine the aetiology of the disease represented 10% of all cases referred for liver biopsy for persistent elevation of serum transaminases. Approximately 50% of patients had chronic hepatitis or cirrhosis and the remainder had NASH or non-specific changes. Occult viral infections were found in a high proportion of cases in the first group and in a low percentage of patients in the second.

  • cryptogenic liver disease
  • cryptogenic hepatitis
  • hepatitis B virus
  • hepatitis C virus
  • hepatitis G virus
  • non-alcoholic steatohepatitis
  • Abbreviations used in this paper

    HBV
    hepatitis B virus
    HCV
    hepatitis C virus
    HGV
    hepatitis G virus
    ALT
    alanine aminotransferase
    NASH
    non-alcoholic steatohepatitis
    HBsAg
    hepatitis B virus surface antigen
    PCR
    polymerase chain reaction
    RT-PCR
    reverse transcription-PCR
    HIV
    human immunodeficiency virus
  • Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Abbreviations used in this paper

    HBV
    hepatitis B virus
    HCV
    hepatitis C virus
    HGV
    hepatitis G virus
    ALT
    alanine aminotransferase
    NASH
    non-alcoholic steatohepatitis
    HBsAg
    hepatitis B virus surface antigen
    PCR
    polymerase chain reaction
    RT-PCR
    reverse transcription-PCR
    HIV
    human immunodeficiency virus
  • View Full Text

    Linked Articles